60 milligrams of ENERGI-F705 Tablets for parkinson disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 15 Jun 2026: Trial registered, NCT07647614

The trials

NCT07647614: A Study to Evaluate the Efficacy and Safety of ENERGI-F705 Tablets for Parkinson's Disease

State
Not started
Phase
Phase 2
People
105 planned
Started
1 Dec 2026
Primary completion
1 Jan 2030
Arms
Low-dose ENERGI-F705 Tablets
Results
None posted
  1. 15 Jun 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.